Fundraising Fox
Keith Crandell
InvestorCo-founder & Managing Director at ARCH Venture Partners
Chicago, Illinois
Writes $50K – $150M checks · typically $25M
Find your path to Keith
Sign up to see every warm intro you have to Keith
- Paths you didn't know you had: your email and LinkedIn already hold routes to Keith. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Keith Crandell follows a follow-the-science approach, prioritizing powerful scientific platforms and tools-focused investments, arguing that better, faster, cheaper measurements—echoing the semiconductor measurement revolution—enable biotech breakthroughs.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical Devices
Deals · 7
Arbor BiotechnologiesBoard seat
via ARCH Venture Partners · filed Nov 2021 · $215M raise
Cytrellis BiosystemsBoard seat
via ARCH Venture Partners · filed Jan 2021 · $50M raise
QuanterixBoard seat
via ARCH Venture Partners · filed Jul 2019 · $6.5M raise
Twist BioscienceBoard seat
via ARCH Venture Partners · filed Dec 2017 · $75M raise
Adesto TechnologiesBoard seat
via ARCH Venture Partners · filed Sep 2015 · $12.5M raise
908 DevicesBoard seat
via ARCH Venture Partners · filed May 2015
NanosysBoard seat
via ARCH Venture Partners · filed Mar 2015 · $10M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Ahura ScientificAlfalightBoreal GenomicsCiespaceCrystal ISOne BioMedONITeach.comUltivueUltraDx BioUnivaVizgenロゴマーク：AIRNA
Sources: SEC Form D filings · curated public sources.
Colleagues at ARCH Venture Partners
Network2
Investors connected to Keith in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Keith Crandell?
- Keith Crandell follows a follow-the-science approach, prioritizing powerful scientific platforms and tools-focused investments, arguing that better, faster, cheaper measurements—echoing the semiconductor measurement revolution—enable biotech breakthroughs.
- Where does Keith Crandell work?
- Keith Crandell is Co-founder & Managing Director at ARCH Venture Partners.
- What does Keith Crandell invest in?
- Keith Crandell invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Medical Devices.
- What check size does Keith Crandell write?
- Keith Crandell typically writes checks of $50K – $150M.
- What boards does Keith Crandell sit on?
- Keith Crandell holds tracked board seats at 908 Devices, Adesto Technologies, Arbor Biotechnologies, Cytrellis Biosystems, Nanosys, Quanterix, Twist Bioscience, Ultivue, Vizgen.
- What companies has Keith Crandell invested in?
- Investments tracked here include 908 Devices, Adesto Technologies, Ahura Scientific, Alfalight, Arbor Biotechnologies, Boreal Genomics, Ciespace, Crystal IS, Nanosys, One BioMed, ONI, Quanterix, and 6 more.
About this profile. Compiled from public sources — ARCH Venture Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights